Harbin Jixianglong Biotech Co., Ltd. recalls

All Harbin Jixianglong Biotech Co., Ltd. recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (2).

2 recalls published between March 11, 2026 and March 11, 2026. Most common issues: microbial contamination (2), manufacturing practices (cgmp) (2).

• Semaglutide, For Rx compounding use only, packaged in a) 1g recall
  FDA March 11, 2026 · Harbin Jixianglong Biotech Co., Ltd. · Class II
• Semaglutide, For Rx compounding use only, packaged in a) 1g recall
  FDA March 11, 2026 · Harbin Jixianglong Biotech Co., Ltd. · Class II